surmount-1 tirzepatide 15 mg weight loss percent reduction over time in tirzepatide‐treated participants by early weight response: Post hoc analysis in SURMOUNT‐1 - Ard - 2025 - Diabetes, Obesity and Metabolism Adults with obesity using tirzepatide

Dont mention GLP-1s: Although 59% of diners would be likely to order smaller, protein-based menu items, over 37% say they are absolutely not interested in a menu labeled as GLP-1 meaning there is interest in the offering but not the identity 7

Under the Hood: A Pharmacists Geek-Out Moment For fellow science aficionados, orforglipron is fascinating due to its non-peptide, small-molecule structure

Reminder: Both routes are clinician-guided and require a prescription

MDL, Class Action, or Mass Tort Coordination: Given the scale of GLP-1 litigation, your attorney may evaluate whether to file your case as part of an existing MDL proceeding or another coordinated legal action